A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window
Standard
A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window. / Bendszus, Martin; Bonekamp, Susanne; Berge, Eivind; Boutitie, Florent; Brouwer, Patrick; Gizewski, Elke; Krajina, Antonin; Pierot, Laurent; Randall, Gary; Simonsen, Claus Z; Zeleňák, Kamil; Fiehler, Jens; Thomalla, Götz.
In: INT J STROKE, Vol. 14, No. 1, 01.2019, p. 87-93.Research output: SCORING: Contribution to journal › SCORING: Journal article › Research › peer-review
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - A randomized controlled trial to test efficacy and safety of thrombectomy in stroke with extended lesion and extended time window
AU - Bendszus, Martin
AU - Bonekamp, Susanne
AU - Berge, Eivind
AU - Boutitie, Florent
AU - Brouwer, Patrick
AU - Gizewski, Elke
AU - Krajina, Antonin
AU - Pierot, Laurent
AU - Randall, Gary
AU - Simonsen, Claus Z
AU - Zeleňák, Kamil
AU - Fiehler, Jens
AU - Thomalla, Götz
PY - 2019/1
Y1 - 2019/1
N2 - RATIONALE: The benefit of thrombectomy in patients with intracranial large vessel occlusion of the anterior circulation has been shown in selected patients in previous randomized controlled trials, but patients with extended ischemic lesions were excluded in the majority of these trials. TENSION aims to demonstrate efficacy and safety of thrombectomy in patients with extended lesions in an extended time window (up to 12 h from onset or from last seen well).DESIGN: TENSION is an investigator-initiated, randomized controlled, open label, blinded endpoint, European, two-arm, postmarket study to compare the safety and effectiveness of thrombectomy as compared to best medical care alone in stroke patients with extended stroke lesions defined by an Alberta Stroke Program Early Computed Tomography Scan score of 3-5 and in an extended time window. In an adaptive design study, up to 665 patients will be randomized.OUTCOMES: Primary efficacy endpoint will be clinical outcome defined by the modified Rankin Scale at 90-day poststroke. The main safety endpoint will be death and dependency (modified Rankin Scale 4-6) at 90 days. Additional effect measures include adverse events, health-related quality of life, poststroke depression, and costs utility assessment.DISCUSSION: TENSION may make effective treatment available for patients with severe stroke in an extended time window, thereby improving functional outcome and quality of life of thousands of stroke patients and reducing the individual, societal, and economic burden of death and disability resulting from severe stroke. TENSION is registered at ClinicalTrials.gov (ClinicalTrials.gov Identifier NCT03094715).
AB - RATIONALE: The benefit of thrombectomy in patients with intracranial large vessel occlusion of the anterior circulation has been shown in selected patients in previous randomized controlled trials, but patients with extended ischemic lesions were excluded in the majority of these trials. TENSION aims to demonstrate efficacy and safety of thrombectomy in patients with extended lesions in an extended time window (up to 12 h from onset or from last seen well).DESIGN: TENSION is an investigator-initiated, randomized controlled, open label, blinded endpoint, European, two-arm, postmarket study to compare the safety and effectiveness of thrombectomy as compared to best medical care alone in stroke patients with extended stroke lesions defined by an Alberta Stroke Program Early Computed Tomography Scan score of 3-5 and in an extended time window. In an adaptive design study, up to 665 patients will be randomized.OUTCOMES: Primary efficacy endpoint will be clinical outcome defined by the modified Rankin Scale at 90-day poststroke. The main safety endpoint will be death and dependency (modified Rankin Scale 4-6) at 90 days. Additional effect measures include adverse events, health-related quality of life, poststroke depression, and costs utility assessment.DISCUSSION: TENSION may make effective treatment available for patients with severe stroke in an extended time window, thereby improving functional outcome and quality of life of thousands of stroke patients and reducing the individual, societal, and economic burden of death and disability resulting from severe stroke. TENSION is registered at ClinicalTrials.gov (ClinicalTrials.gov Identifier NCT03094715).
KW - Adult
KW - Aged
KW - Aged, 80 and over
KW - Brain Ischemia/mortality
KW - Disease Progression
KW - Endovascular Procedures
KW - Europe
KW - Female
KW - Fibrinolytic Agents/therapeutic use
KW - Humans
KW - Male
KW - Middle Aged
KW - Severity of Illness Index
KW - Stroke/mortality
KW - Survival Analysis
KW - Thrombectomy
KW - Time Factors
KW - Tomography, X-Ray Computed
KW - Treatment Outcome
KW - Young Adult
U2 - 10.1177/1747493018798558
DO - 10.1177/1747493018798558
M3 - SCORING: Journal article
C2 - 30156479
VL - 14
SP - 87
EP - 93
JO - INT J STROKE
JF - INT J STROKE
SN - 1747-4930
IS - 1
ER -